{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T13:32:03Z","timestamp":1762522323483,"version":"build-2065373602"},"reference-count":96,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.es","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Reumatolog\u00eda Cl\u00ednica"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1016\/j.reuma.2019.03.010","type":"journal-article","created":{"date-parts":[[2019,7,6]],"date-time":"2019-07-06T00:46:55Z","timestamp":1562374015000},"page":"37-45","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Recomendaciones del Colegio Mexicano de Reumatolog\u00eda para el manejo de las espondiloartritis"],"prefix":"10.1016","volume":"17","author":[{"given":"Greta","family":"Reyes-Cordero","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Favio","family":"Enr\u00edquez-Sosa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Citlallyc","family":"Gomez-Ruiz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ver\u00f3nica","family":"Gonzalez-Diaz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9 Dionisio","family":"Castillo-Ortiz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sergio","family":"Duran-Barrag\u00e1n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. Santos","family":"Duran-Ortiz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rolando","family":"Espinosa-Morales","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jorge I.","family":"Gamez-Nava","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura","family":"Gonzalez-Lopez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bernardo","family":"Julian-Mart\u00ednez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ang\u00e9lica","family":"Mendoza-Fuentes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cesar","family":"Ramos-Remus","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cesar","family":"Pacheco-Tena","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ruben","family":"Burgos-Vargas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.reuma.2019.03.010_bib0485","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.cnur.2015.03.007","article-title":"Utilization of clinical practice guidelines: barriers and facilitators","volume":"50","author":"Keiffer","year":"2015","journal-title":"Nurs Clin North Am."},{"key":"10.1016\/j.reuma.2019.03.010_bib0490","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/1748-5908-7-62","article-title":"Developing clinical practice guidelines: reviewing, reporting, and publishing guidelines; updating guidelines; and the emerging issues of enhancing guideline implementability and accounting for comorbid conditions in guideline development","volume":"7","author":"Shekelle","year":"2012","journal-title":"Implement Sci."},{"issue":"Suppl. 2","key":"10.1016\/j.reuma.2019.03.010_bib0495","doi-asserted-by":"crossref","first-page":"S24","DOI":"10.1016\/S1699-258X(05)72770-4","article-title":"[Effectiveness of biological agents in ankylosing spondylitis]","volume":"1","author":"Burgos-Vargas","year":"2005","journal-title":"Reumatol Clin."},{"key":"10.1016\/j.reuma.2019.03.010_bib0500","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/S1699-258X(06)73026-1","article-title":"Gu\u00edas y recomendaciones del Colegio Mexicano de Reumatolog\u00eda para el uso de agentes biol\u00f3gicos en enfermos reum\u00e1ticos","volume":"2","year":"2006","journal-title":"Reumatol Clin."},{"key":"10.1016\/j.reuma.2019.03.010_bib0505","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1136\/ard.2011.151563","article-title":"2010 Update of the international ASAS recommendations for the use of anti-TNF agents in patients with axial spondyloarthritis","volume":"70","author":"Van der Heijde","year":"2011","journal-title":"Ann Rheum Dis."},{"key":"10.1016\/j.reuma.2019.03.010_bib0510","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1136\/ard.2006.053397","article-title":"Agreement of Mexican rheumatologists with the Assessment in Ankylosing Spondylitis International Working Group and the European League Against Rheumatism recommendations for the management of ankylosing spondylitis","volume":"65","author":"Sim\u00f3n","year":"2006","journal-title":"Ann Rheum Dis."},{"key":"10.1016\/j.reuma.2019.03.010_bib0515","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1136\/annrheumdis-2016-210770","article-title":"2016 update of the ASAS-EULAR management recommendations for axial spondyloarthritis","volume":"76","author":"Van der Heijde","year":"2017","journal-title":"Ann Rheum Dis."},{"key":"10.1016\/j.reuma.2019.03.010_bib0520","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1136\/ard.2005.041137","article-title":"ASAS\/EULAR recommendations for the management of ankylosing spondylitis","volume":"65","author":"Zochling","year":"2006","journal-title":"Ann Rheum Dis."},{"key":"10.1016\/j.reuma.2019.03.010_bib0525","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1136\/ard.2011.151027","article-title":"2010 update of the ASAS\/EULAR recommendations for the management of ankylosing spondylitis","volume":"70","author":"Braun","year":"2011","journal-title":"Ann Rheum Dis."},{"key":"10.1016\/j.reuma.2019.03.010_bib0530","first-page":"2286","article-title":"A new approach to defining disease status in ankylosing spondylitis: The Bath Ankylosing Spondylitis Disease Activity Index","volume":"21","author":"Garrett","year":"1994","journal-title":"J Rheumatol."},{"key":"10.1016\/j.reuma.2019.03.010_bib0535","first-page":"451","volume":"21","author":"Cardiel","year":"2003","journal-title":"Clin Exp Rheumatol."},{"key":"10.1016\/j.reuma.2019.03.010_bib0540","doi-asserted-by":"crossref","first-page":"1876","DOI":"10.1002\/1529-0131(200108)44:8<1876::AID-ART326>3.0.CO;2-F","article-title":"Ankylosing spondylitis assessment group preliminary definition of short-term improvement in ankylosing spondylitis","volume":"44","author":"Anderson","year":"2001","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.reuma.2019.03.010_bib0545","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1136\/ard.2003.016717","article-title":"Development and preselection of criteria for short term improvement after anti-TNF alpha treatment in ankylosing spondylitis","volume":"63","author":"Brandt","year":"2004","journal-title":"Ann Rheum Dis."},{"key":"10.1016\/j.reuma.2019.03.010_bib0550","doi-asserted-by":"crossref","first-page":"2263","DOI":"10.1002\/1529-0131(199812)41:12<2263::AID-ART23>3.0.CO;2-I","article-title":"The Bath Ankylosing Spondylitis Radiology Index (BASRI): a new, validated approach to disease assessment","volume":"41","author":"MacKay","year":"1998","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.reuma.2019.03.010_bib0555","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1136\/ard.2004.020503","article-title":"Assessment of outcome in ankylosing spondylitis: an extended radiographic scoring system","volume":"64","author":"Creemers","year":"2005","journal-title":"Ann Rheum Dis."},{"key":"10.1016\/j.reuma.2019.03.010_bib0560","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1136\/ard.2009.110767","article-title":"Defining active sacroiliitis on magnetic resonance imaging (MRI) for classification of axial spondyloarthritis: a consensual approach by the ASAS\/OMERACT MRI group","volume":"68","author":"Rudwaleit","year":"2009","journal-title":"Ann Rheum Dis."},{"key":"10.1016\/j.reuma.2019.03.010_bib0565","doi-asserted-by":"crossref","first-page":"1958","DOI":"10.1136\/annrheumdis-2015-208642","article-title":"Defining active sacroiliitis on MRI for classification of axial spondyloarthritis: update by the ASAS MRI working group","volume":"75","author":"Lambert","year":"2016","journal-title":"Ann Rheum Dis."},{"key":"10.1016\/j.reuma.2019.03.010_bib0570","doi-asserted-by":"crossref","first-page":"79","DOI":"10.3899\/jrheum.140519","article-title":"Development and preliminary validation of the spondyloarthritis research consortium of Canada magnetic resonance imaging sacroiliac joint structural score","volume":"42","author":"Maksymowych","year":"2015","journal-title":"J Rheumatol."},{"key":"10.1016\/j.reuma.2019.03.010_bib0575","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1136\/bmj.39489.470347.AD","article-title":"GRADE: an emerging consensus on rating quality of evidence and strength of recommendations","volume":"336","author":"Guyatt","year":"2008","journal-title":"BMJ."},{"key":"10.1016\/j.reuma.2019.03.010_bib0580","unstructured":"OCEBM Levels of Evidence [Internet]. CEBM. 2016 [consultado 20 Mar 2017]. Disponible en: https:\/\/www.cebm.net\/2016\/05\/ocebm-levels-of-evidence\/"},{"key":"10.1016\/j.reuma.2019.03.010_bib0585","doi-asserted-by":"crossref","first-page":"2649","DOI":"10.1002\/art.38776","article-title":"The concept of axial spondyloarthritis: joint statement of the spondyloarthritis research and treatment network and the Assessment of SpondyloArthritis international Society in response to the US Food and Drug Administration's comments and concerns","volume":"66","author":"Deodhar","year":"2014","journal-title":"Arthritis Rheumatol."},{"key":"10.1016\/j.reuma.2019.03.010_bib0590","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1016\/S0140-6736(07)60635-7","article-title":"Ankylosing spondylitis","volume":"369","author":"Braun","year":"2007","journal-title":"Lancet."},{"key":"10.1016\/j.reuma.2019.03.010_bib0595","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1136\/ard.2009.108217","article-title":"The development of Assessment of SpondyloArthritis international Society classification criteria for axial spondyloarthritis (part I): Classification of paper patients by expert opinion including uncertainty appraisal","volume":"68","author":"Rudwaleit","year":"2009","journal-title":"Ann Rheum Dis."},{"key":"10.1016\/j.reuma.2019.03.010_bib0600","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1136\/ard.2009.108233","article-title":"The development of Assessment of SpondyloArthritis international Society classification criteria for axial spondyloarthritis (part II): Validation and final selection","volume":"686","author":"Rudwaleit","year":"2009","journal-title":"Ann Rheum Dis."},{"key":"10.1016\/j.reuma.2019.03.010_bib0605","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1136\/ard.2010.133645","article-title":"The Assessment of SpondyloArthritis international Society classification criteria for peripheral spondyloarthritis and for spondyloarthritis in general","volume":"70","author":"Rudwaleit","year":"2011","journal-title":"Ann Rheum Dis."},{"key":"10.1016\/j.reuma.2019.03.010_bib0610","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1002\/art.1780270401","article-title":"Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria","volume":"27","author":"Van der Linden","year":"1984","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.reuma.2019.03.010_bib0615","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.3899\/jrheum.130460","article-title":"Peripheral spondyloarthritis and psoriatic arthritis; overlaps and distinctions: a report from the GRAPPA 2012 annual meeting","volume":"40","author":"Helliwell","year":"2013","journal-title":"J Rheumatol."},{"key":"10.1016\/j.reuma.2019.03.010_bib0620","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1097\/BOR.0b013e32835fd8d5","article-title":"Psoriatic arthritis and spondyloarthritis assessment and management update","volume":"25","author":"Mease","year":"2013","journal-title":"Curr Opin Rheumatol."},{"key":"10.1016\/j.reuma.2019.03.010_bib0625","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1002\/art.1780341003","article-title":"The European Spondylarthropathy Study Group preliminary criteria for the classification of spondylarthropathy","volume":"34","author":"Dougados","year":"1991","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.reuma.2019.03.010_bib0630","first-page":"186","article-title":"Ankylosing spondylitis in the Mexican mestizo: patterns of disease according to age at onset","volume":"16","author":"Burgos-Vargas","year":"1989","journal-title":"J Rheumatol."},{"key":"10.1016\/j.reuma.2019.03.010_bib0635","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.3899\/jrheum.101049","article-title":"Differential features between primary ankylosing spondylitis and spondylitis associated with psoriasis and inflammatory bowel disease","volume":"38","author":"Perez Alamino","year":"2011","journal-title":"J Rheumatol."},{"key":"10.1016\/j.reuma.2019.03.010_bib0640","doi-asserted-by":"crossref","first-page":"2315","DOI":"10.3899\/jrheum.110687","article-title":"Comparison of the clinical expression of patients with ankylosing spondylitis from Europe and Latin America","volume":"39","author":"Benegas","year":"2012","journal-title":"J Rheumatol."},{"key":"10.1016\/j.reuma.2019.03.010_bib0645","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1093\/rheumatology\/kep174","article-title":"Hip involvement in ankylosing spondylitis: epidemiology and risk factors associated with hip replacement surgery","volume":"49","author":"Vander Cruyssen","year":"2010","journal-title":"Rheumatology (Oxford)."},{"key":"10.1016\/j.reuma.2019.03.010_bib0650","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1007\/s11926-014-0438-3","article-title":"Seronegative arthritis in Latin America: a current review","volume":"16","author":"Saad","year":"2014","journal-title":"Curr Rheumatol Rep."},{"key":"10.1016\/j.reuma.2019.03.010_bib0655","doi-asserted-by":"crossref","first-page":"e5652","DOI":"10.1097\/MD.0000000000005652","article-title":"Gender differences among patients with primary ankylosing spondylitis and spondylitis associated with psoriasis and inflammatory bowel disease in an Iberoamerican spondyloarthritis cohort","volume":"95","author":"Landi","year":"2016","journal-title":"Medicine."},{"key":"10.1016\/j.reuma.2019.03.010_bib0660","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1097\/RHU.0b013e3182862e65","article-title":"A community-based study on the prevalence of spondyloarthritis and inflammatory back pain in Mexicans","volume":"19","author":"Pel\u00e1ez-Ballestas","year":"2013","journal-title":"J Clin Rheumatol."},{"key":"10.1016\/j.reuma.2019.03.010_bib0665","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1093\/rheumatology\/37.11.1215","article-title":"Referral and diagnosis of common rheumatic diseases by primary care physicians","volume":"37","author":"Gamez-Nava","year":"1998","journal-title":"Br J Rheumatol."},{"key":"10.1016\/j.reuma.2019.03.010_bib0670","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/0198-8859(94)00156-K","article-title":"Characterization of B27 haplotypes by oligotyping and genomic sequencing in the Mexican Mestizo population with ankylosing spondylitis: juvenile and adult onset","volume":"43","author":"Lopez-Larrea","year":"1995","journal-title":"Hum Immunol."},{"key":"10.1016\/j.reuma.2019.03.010_bib0675","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1136\/ard.61.8.714","article-title":"Effect of HLA-B and HLA-DR genes on susceptibility to and severity of spondyloarthropathies in Mexican patients","volume":"61","author":"Vargas-Alarc\u00f3n","year":"2002","journal-title":"Ann Rheum Dis."},{"key":"10.1016\/j.reuma.2019.03.010_bib0680","first-page":"225","article-title":"[Social costs of the most common inflammatory rheumatic diseases in Mexico from the patient's perspective]","volume":"144","author":"Mould-Quevedo","year":"2008","journal-title":"Gac Med."},{"key":"10.1016\/j.reuma.2019.03.010_bib0685","first-page":"41","article-title":"Fundamentos para el tratamiento de la espondilitis anquilosante y su efecto en la reumatolog\u00eda mexicana","volume":"145","author":"Burgos-Vargas","year":"2009","journal-title":"Gac M\u00e9d M\u00e9x."},{"key":"10.1016\/j.reuma.2019.03.010_bib0690","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1136\/annrheumdis-2015-208174","article-title":"Prevalence of comorbidities and evaluation of their screening in spondyloarthritis: results of the international cross-sectional ASAS-COMOSPA study","volume":"75","author":"Molt\u00f3","year":"2016","journal-title":"Ann Rheum Dis."},{"key":"10.1016\/j.reuma.2019.03.010_bib0695","doi-asserted-by":"crossref","first-page":"480","DOI":"10.3109\/03009742.2016.1152399","article-title":"Association between bone turnover markers, clinical variables, spinal syndesmophytes and bone mineral density in Mexican patients with ankylosing spondylitis","volume":"45","author":"Gamez-Nava","year":"2016","journal-title":"Scand J Rheumatol."},{"key":"10.1016\/j.reuma.2019.03.010_bib0700","first-page":"7","article-title":"Prevalence of obesity and metabolic syndrome components in Mexican adults without type 2 diabetes or hypertension","volume":"54","author":"Rojas-Mart\u00ednez","year":"2012","journal-title":"Salud P\u00fablica M\u00e9x."},{"key":"10.1016\/j.reuma.2019.03.010_bib0705","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.reuma.2012.05.002","article-title":"Catastrophic health expenses and impoverishment of households of patients with rheumatoid arthritis","volume":"8","author":"\u00c1lvarez-Hern\u00e1ndez","year":"2012","journal-title":"Reumatol Clin."},{"key":"10.1016\/j.reuma.2019.03.010_bib0710","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1007\/s00393-009-0464-0","article-title":"Dissemination and evaluation of ASAS\/EULAR recommendations for the management of ankylosing spondylitis in Europe","volume":"68","author":"Braun","year":"2009","journal-title":"Z Rheumatol."},{"issue":"Supl. 2","key":"10.1016\/j.reuma.2019.03.010_bib0715","doi-asserted-by":"crossref","first-page":"S60","DOI":"10.1016\/S1699-258X(07)73645-8","article-title":"Actualizaci\u00f3n del Consenso de la Sociedad Espa\u00f1ola de Reumatolog\u00eda sobre el uso de antagonistas del TNF\u03b1 en las espondiloartritis, incluida la artritis psori\u00e1sica","volume":"3","author":"Collantes","year":"2007","journal-title":"Reumatol Clin."},{"key":"10.1016\/j.reuma.2019.03.010_bib0720","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1136\/ard.2007.080077","article-title":"Dissemination and evaluation of the ASAS\/EULAR recommendations for the management of ankylosing spondylitis: results of a study among 1507 rheumatologists","volume":"67","author":"Gossec","year":"2008","journal-title":"Ann Rheum Dis."},{"key":"10.1016\/j.reuma.2019.03.010_bib0725","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/s00393-012-1071-z","article-title":"[ASAS\/EULAR recommendations for the management of ankylosing spondylitis: evaluation of the 2010 update in the German-speaking area]","volume":"72","author":"Kiltz","year":"2013","journal-title":"Z Rheumatol."},{"key":"10.1016\/j.reuma.2019.03.010_bib0730","doi-asserted-by":"crossref","first-page":"654","DOI":"10.3899\/jrheum.141000","article-title":"2014 Update of the Canadian Rheumatology Association\/spondyloarthritis research consortium of Canada treatment recommendations for the management of spondyloarthritis. Part I: Principles of the management of spondyloarthritis in Canada","volume":"42","author":"Rohekar","year":"2015","journal-title":"J Rheumatol."},{"key":"10.1016\/j.reuma.2019.03.010_bib0735","doi-asserted-by":"crossref","first-page":"665","DOI":"10.3899\/jrheum.141001","article-title":"2014 Update of the Canadian Rheumatology Association\/spondyloarthritis research consortium of Canada treatment recommendations for the management of spondyloarthritis. Part II: Specific management recommendations","volume":"42","author":"Rohekar","year":"2015","journal-title":"J Rheumatol."},{"key":"10.1016\/j.reuma.2019.03.010_bib0740","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.jbspin.2013.12.002","article-title":"Recommendations of the French Society for Rheumatology (SFR) on the everyday management of patients with spondyloarthritis","volume":"81","author":"Wendling","year":"2014","journal-title":"Joint Bone Spine."},{"key":"10.1016\/j.reuma.2019.03.010_bib0745","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.jbspin.2018.01.006","article-title":"2018 update of French Society for Rheumatology (SFR) recommendations about the everyday management of patients with spondyloarthritis","volume":"85","author":"Wendling","year":"2018","journal-title":"Joint Bone Spine."},{"key":"10.1016\/j.reuma.2019.03.010_bib0750","first-page":"209","article-title":"Portuguese recommendations for the use of biological therapies in patients with axial spondyloarthritis - 2016 update","volume":"42","author":"Machado","year":"2017","journal-title":"Acta Reumatol Port."},{"key":"10.1016\/j.reuma.2019.03.010_bib0755","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1136\/annrheumdis-2017-211734","article-title":"Treating axial spondyloarthritis and peripheral spondyloarthritis, especially psoriatic arthritis, to target: 2017 update of recommendations by an international task force","volume":"77","author":"Smolen","year":"2018","journal-title":"Ann Rheum Dis."},{"key":"10.1016\/j.reuma.2019.03.010_bib0760","doi-asserted-by":"crossref","first-page":"e000397","DOI":"10.1136\/rmdopen-2016-000397","article-title":"Efficacy and safety of non-pharmacological and non-biological pharmacological treatment: a systematic literature review informing the 2016 update of the ASAS\/EULAR recommendations for the management of axial spondyloarthritis","volume":"3","author":"Regel","year":"2017","journal-title":"RMD Open."},{"key":"10.1016\/j.reuma.2019.03.010_bib0765","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1093\/rheumatology\/kem348","article-title":"Evidence-based recommendations for the management of ankylosing spondylitis: systematic literature search of the 3E Initiative in Rheumatology involving a broad panel of experts and practising rheumatologists","volume":"47","author":"Sidiropoulos","year":"2008","journal-title":"Rheumatology (Oxford)."},{"key":"10.1016\/j.reuma.2019.03.010_bib0770","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.1136\/ard.2005.042630","article-title":"An international study on starting tumour necrosis factor-blocking agents in ankylosing spondylitis","volume":"65","author":"Pham","year":"2006","journal-title":"Ann Rheum Dis."},{"key":"10.1016\/j.reuma.2019.03.010_bib0775","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1002\/art.39298","article-title":"American College of Rheumatology\/Spondylitis Association of America\/Spondyloarthritis Research and Treatment Network 2015 Recommendations for the treatment of ankylosing spondylitis and nonradiographic axial spondyloarthritis","volume":"68","author":"Ward","year":"2016","journal-title":"Arthritis Rheumatol."},{"key":"10.1016\/j.reuma.2019.03.010_bib0780","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.reuma.2017.08.008","article-title":"Recommendations by the Spanish Society of Rheumatology on the use of biological therapies in axial spondyloarthritis","volume":"14","author":"Gratac\u00f3s","year":"2018","journal-title":"Reumatol Clin."},{"key":"10.1016\/j.reuma.2019.03.010_bib0785","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1093\/rheumatology\/kew367","article-title":"Efficiency of treatment with non-steroidal anti-inflammatory drugs according to current recommendations in patients with radiographic and non-radiographic axial spondyloarthritis","volume":"56","author":"Baraliakos","year":"2017","journal-title":"Rheumatology (Oxford)."},{"key":"10.1016\/j.reuma.2019.03.010_bib0790","doi-asserted-by":"crossref","first-page":"R439","DOI":"10.1186\/ar1693","article-title":"Clinical response to discontinuation of anti-TNF therapy in patients with ankylosing spondylitis after 3 years of continuous treatment with infliximab","volume":"7","author":"Baraliakos","year":"2005","journal-title":"Arthritis Res Ther."},{"key":"10.1016\/j.reuma.2019.03.010_bib0795","doi-asserted-by":"crossref","first-page":"341","DOI":"10.3899\/jrheum.170487","article-title":"Safety and efficacy of golimumab administered intravenously in adults with ankylosing spondylitis: results through week 28 of the GO-ALIVE Study","volume":"45","author":"Deodhar","year":"2018","journal-title":"J Rheumatol."},{"key":"10.1016\/j.reuma.2019.03.010_bib0800","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1093\/rheumatology\/kex174","article-title":"Sustained efficacy, safety and patient-reported outcomes of certolizumab pegol in axial spondyloarthritis: 4-year outcomes from RAPID-axSpA","volume":"56","author":"Van der Heijde","year":"2017","journal-title":"Rheumatology (Oxford)."},{"key":"10.1016\/j.reuma.2019.03.010_bib0805","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1136\/annrheumdis-2016-209730","article-title":"Effect of secukinumab on clinical and radiographic outcomes in ankylosing spondylitis: 2-year results from the randomised phase III MEASURE 1 study","volume":"76","author":"Braun","year":"2017","journal-title":"Ann Rheum Dis."},{"key":"10.1016\/j.reuma.2019.03.010_bib0810","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1186\/s13075-017-1490-y","article-title":"Efficacy, safety, and tolerability of secukinumab in patients with active ankylosing spondylitis: a randomized, double-blind phase 3 study, MEASURE 3","volume":"19","author":"Pavelka","year":"2017","journal-title":"Arthritis Res Ther."},{"key":"10.1016\/j.reuma.2019.03.010_bib0815","doi-asserted-by":"crossref","first-page":"101","DOI":"10.3899\/jrheum.140229","article-title":"Treatment with tumor necrosis factor inhibitors in axial spondyloarthritis: comparison between private rheumatology practices and academic centers in a large observational cohort","volume":"42","author":"Ciurea","year":"2015","journal-title":"J Rheumatol;"},{"key":"10.1016\/j.reuma.2019.03.010_bib0820","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1136\/annrheumdis-2017-eular.3321","article-title":"Efficacy and safety of switching from reference infliximab to CT-P13 compared with maintenance of CT-P13 in ankylosing spondylitis: 102-week data from the PLANETAS extension study","volume":"76","author":"Park","year":"2017","journal-title":"Ann Rheum Dis."},{"key":"10.1016\/j.reuma.2019.03.010_bib0825","doi-asserted-by":"crossref","first-page":"481","DOI":"10.3899\/jrheum.170224","article-title":"Comparative efficacy of tumor necrosis factor-\u03b1 inhibitors in ankylosing spondylitis: a systematic review and Bayesian network metaanalysis","volume":"45","author":"Wang","year":"2018","journal-title":"J Rheumatol."},{"key":"10.1016\/j.reuma.2019.03.010_bib0830","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1007\/s10067-017-3966-1","article-title":"Risk of serious infections in biological treatment of patients with ankylosing spondylitis and non-radiographic axial spondyloarthritis: a meta-analysis","volume":"37","author":"Wang","year":"2018","journal-title":"Clin Rheumatol."},{"key":"10.1016\/j.reuma.2019.03.010_bib0835","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1007\/s12016-017-8623-6","article-title":"The comparative safety of TNF inhibitors in ankylosing spondylitis-a meta-analysis update of 14 randomized controlled trials","volume":"54","author":"Hou","year":"2018","journal-title":"Clin Rev Allergy Immunol."},{"key":"10.1016\/j.reuma.2019.03.010_bib0840","doi-asserted-by":"crossref","first-page":"32768","DOI":"10.1038\/srep32768","article-title":"Efficacy and safety of TNF-\u03b1 inhibitors for active ankylosing spondylitis patients: multiple treatment comparisons in a network meta-analysis","volume":"6","author":"Liu","year":"2016","journal-title":"Sci Rep."},{"key":"10.1016\/j.reuma.2019.03.010_bib0845","doi-asserted-by":"crossref","first-page":"e3060","DOI":"10.1097\/MD.0000000000003060","article-title":"Comparative effectiveness of biologic therapy regimens for ankylosing spondylitis: a systematic review and a network meta-analysis","volume":"95","author":"Chen","year":"2016","journal-title":"Medicine."},{"key":"10.1016\/j.reuma.2019.03.010_bib0850","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1136\/annrheumdis-2015-207677","article-title":"Comparative efficacy of non-steroidal anti-inflammatory drugs in ankylosing spondylitis: a Bayesian network meta-analysis of clinical trials","volume":"75","author":"Wang","year":"2016","journal-title":"Ann Rheum Dis."},{"key":"10.1016\/j.reuma.2019.03.010_bib0855","first-page":"935","article-title":"Efficacy, safety and cost per responder of biologics in the treatment of non-radiographic axial spondyloarthritis","volume":"34","author":"Olivieri","year":"2016","journal-title":"Clin Exp Rheumatol."},{"key":"10.1016\/j.reuma.2019.03.010_bib0860","first-page":"CD005468","article-title":"TNF-alpha inhibitors for ankylosing spondylitis","volume":"18","author":"Maxwell","year":"2015","journal-title":"Cochrane Database Syst Rev."},{"key":"10.1016\/j.reuma.2019.03.010_bib0865","doi-asserted-by":"crossref","first-page":"341","DOI":"10.3899\/jrheum.170487","article-title":"Safety and Efficacy of golimumab administered intravenously in adults with ankylosing spondylitis: results through week 28 of the GO-ALIVE Study","volume":"45","author":"Deodhar","year":"2018","journal-title":"J Rheumatol."},{"key":"10.1016\/j.reuma.2019.03.010_bib0870","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.1002\/acr.23276","article-title":"Effects of long-term etanercept treatment on clinical outcomes and objective signs of inflammation in early nonradiographic axial spondyloarthritis: 104-week results from a randomized placebo-controlled study","volume":"69","author":"Dougados","year":"2017","journal-title":"Arthritis Care Res."},{"key":"10.1016\/j.reuma.2019.03.010_bib0875","doi-asserted-by":"crossref","first-page":"e000430","DOI":"10.1136\/rmdopen-2017-000430","article-title":"Effect of certolizumab pegol over 96 weeks of treatment on inflammation of the spine and sacroiliac joints, as measured by MRI, and the association between clinical and MRI outcomes in patients with axial spondyloarthritis","volume":"3","author":"Braun","year":"2017","journal-title":"RMD Open."},{"key":"10.1016\/j.reuma.2019.03.010_bib0880","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1093\/rheumatology\/kex174","article-title":"Sustained efficacy, safety and patient-reported outcomes of certolizumab pegol in axial spondyloarthritis: 4-year outcomes from RAPID-axSpA","volume":"56","author":"Van der Heijde","year":"2017","journal-title":"Rheumatology (Oxford)."},{"key":"10.1016\/j.reuma.2019.03.010_bib0885","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1136\/annrheumdis-2016-209730","article-title":"Effect of secukinumab on clinical and radiographic outcomes in ankylosing spondylitis: 2-year results from the randomised phase III MEASURE 1 study","volume":"76","author":"Braun","year":"2017","journal-title":"Ann Rheum Dis."},{"key":"10.1016\/j.reuma.2019.03.010_bib0890","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1186\/s13075-017-1490-y","article-title":"Efficacy, safety, and tolerability of secukinumab in patients with active ankylosing spondylitis: a randomized, double-blind phase 3 study, MEASURE 3","volume":"19","author":"Pavelka","year":"2017","journal-title":"Arthritis Res Ther."},{"key":"10.1016\/j.reuma.2019.03.010_bib0895","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1136\/annrheumdis-2017-eular.3321","article-title":"Efficacy and safety of switching from reference infliximab to CT-P13 compared with maintenance of CT-P13 in ankylosing spondylitis: 102-week data from the PLANETAS extension study","volume":"76","author":"Park","year":"2017","journal-title":"Ann Rheum Dis."},{"key":"10.1016\/j.reuma.2019.03.010_bib0900","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1007\/s00296-016-3452-0","article-title":"Assessment of clinical efficacy and safety in a randomized double-blind study of etanercept and sulfasalazine in patients with ankylosing spondylitis from Eastern\/Central Europe, Latin America, and Asia","volume":"36","author":"Damjanov","year":"2016","journal-title":"Rheumatol Int."},{"key":"10.1016\/j.reuma.2019.03.010_bib0905","doi-asserted-by":"crossref","first-page":"2901","DOI":"10.1002\/art.39805","article-title":"Effect of secukinumab on patient-reported outcomes in patients with active ankylosing spondylitis: a phase III randomized trial (MEASURE 1)","volume":"68","author":"Deodhar","year":"2016","journal-title":"Arthritis Rheumatol."},{"key":"10.1016\/j.reuma.2019.03.010_bib0910","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1177\/0300060516628704","article-title":"Celecoxib versus diclofenac for the treatment of ankylosing spondylitis: 12-week randomized study in Norwegian patients","volume":"44","author":"Walker","year":"2016","journal-title":"J Int Med Res."},{"key":"10.1016\/j.reuma.2019.03.010_bib0915","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1136\/annrheumdis-2014-205862","article-title":"Golimumab administered subcutaneously every 4 weeks in ankylosing spondylitis: 5-year results of the GO-RAISE study","volume":"74","author":"Deodhar","year":"2015","journal-title":"Ann Rheum Dis."},{"key":"10.1016\/j.reuma.2019.03.010_bib0920","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.apmr.2017.07.015","article-title":"Effectiveness of exercise programs in ankylosing spondylitis: a meta-analysis of randomized controlled trials","volume":"99","author":"P\u00e9courneau","year":"2018","journal-title":"Arch Phys Med Rehabil."},{"key":"10.1016\/j.reuma.2019.03.010_bib0925","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1007\/s10067-015-2913-2","article-title":"Effects of home-based exercise intervention on health-related quality of life for patients with ankylosing spondylitis: a meta-analysis","volume":"34","author":"Liang","year":"2015","journal-title":"Clin Rheumatol."},{"key":"10.1016\/j.reuma.2019.03.010_bib0930","doi-asserted-by":"crossref","first-page":"1979","DOI":"10.1007\/s00296-017-3829-8","article-title":"The role of land and aquatic exercise in ankylosing spondylitis: a systematic review","volume":"37","author":"Z\u00e3o","year":"2017","journal-title":"Rheumatol Int."},{"key":"10.1016\/j.reuma.2019.03.010_bib0935","first-page":"45","article-title":"Swiss ball exercises improve muscle strength and walking performance in ankylosing spondylitis: a randomized controlled trial","volume":"57","author":"Souza de","year":"2017","journal-title":"Rev Bras Reumatol."},{"key":"10.1016\/j.reuma.2019.03.010_bib0940","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1177\/0269215515578292","article-title":"Inspiratory muscle training improves aerobic capacity and pulmonary function in patients with ankylosing spondylitis: a randomized controlled study","volume":"30","author":"Dr\u0103goi","year":"2016","journal-title":"Clin Rehabil."},{"key":"10.1016\/j.reuma.2019.03.010_bib0945","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1007\/s00296-016-3441-3","article-title":"Effectiveness of ultrasound treatment applied with exercise therapy on patients with ankylosing spondylitis: a double-blind, randomized, placebo-controlled trial","volume":"36","author":"\u015eilte Karamanlio\u011flu","year":"2016","journal-title":"Rheumatol Int."},{"key":"10.1016\/j.reuma.2019.03.010_bib0950","doi-asserted-by":"crossref","first-page":"931","DOI":"10.17219\/acem\/32590","article-title":"The Effectiveness of exergames in patients with ankylosing spondylitis: a randomized controlled trial","volume":"25","author":"Karahan","year":"2016","journal-title":"Adv Clin Exp Med."},{"key":"10.1016\/j.reuma.2019.03.010_bib0955","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/s12893-015-0118-x","article-title":"Comparison of Smith-Petersen osteotomy, pedicular subtraction osteotomy, and poly-segmental wedge osteotomy in treating rigid thoracolumbar kyphotic deformity in ankylosing spondylitis a systematic review and meta-analysis","volume":"16","author":"Hu","year":"2016","journal-title":"BMC Surg."},{"key":"10.1016\/j.reuma.2019.03.010_bib0960","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1097\/BRS.0000000000000815","article-title":"Comparison of Smith-Petersen osteotomy and pedicle subtraction osteotomy for the correction of thoracolumbar kyphotic deformity in ankylosing spondylitis: a systematic review and meta-analysis","volume":"40","author":"Liu","year":"2015","journal-title":"Spine (Phila Pa 1976)."}],"container-title":["Reumatolog\u00eda Cl\u00ednica"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1699258X19300804?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1699258X19300804?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T15:00:22Z","timestamp":1761663622000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1699258X19300804"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1]]},"references-count":96,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,1]]}},"alternative-id":["S1699258X19300804"],"URL":"https:\/\/doi.org\/10.1016\/j.reuma.2019.03.010","relation":{},"ISSN":["1699-258X"],"issn-type":[{"type":"print","value":"1699-258X"}],"subject":[],"published":{"date-parts":[[2021,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Recomendaciones del Colegio Mexicano de Reumatolog\u00eda para el manejo de las espondiloartritis","name":"articletitle","label":"Article Title"},{"value":"Reumatolog\u00eda Cl\u00ednica","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.reuma.2019.03.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Espa\u00f1a, S.L.U. and Sociedad Espa\u00f1ola de Reumatolog\u00eda y Colegio Mexicano de Reumatolog\u00eda. All rights reserved.","name":"copyright","label":"Copyright"}]}}